Eli Lilly Bets on Oura Rings
Pharmaceutical giants are realizing that selling a weight-loss drug is only half the battle.
July 17, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🩺 Endocrinology.
Telehealth GLP-1 sales bypass clinical safety
Getting a prescription for the world’s most sought-after weight-loss drugs has devolved into a frictionless, five-minute checkout process.
July 8, 2026
FDA Crackdown Hits Telehealth GLP-1 Sales
The wild west of online weight-loss drug marketing is officially coming to an end.
July 5, 2026
AI predicts sudden blood pressure drops in diabetics
A new algorithm spots which diabetic patients will crash after surgery, shifting the focus from reactive emergency care to proactive recovery.
July 1, 2026
AI Matches Endocrinologists in Insulin Dosing
Algorithms can now recommend insulin doses as safely as human specialists, shifting the bottleneck of diabetes care from clinical expertise to patient trust.
June 25, 2026
Why pharma wants smart rings on GLP-1 patients
A new partnership between a smart ring maker and a pharmaceutical giant reveals how drugmakers are using consumer hardware to keep patients compliant.
June 24, 2026
AI Spots Hidden Cause of High Blood Pressure
An overlooked hormonal condition drives millions of hypertension cases, but a new algorithmic approach could finally bring it into the light.
June 22, 2026
Predicting Diabetes Ten Years Before It Starts
An algorithm that spots diabetes risk a decade early could solve a massive bottleneck in preventive healthcare—if health systems actually know how to act on the data.
June 22, 2026
FDA Clears First Over-the-Counter Kids’ Glucose Monitor
Putting medical-grade metabolic tracking directly into the hands of parents bypasses the clinic but shifts a heavy burden of clinical interpretation to the living room.
June 13, 2026
Enhancements in EPR for Acute Abdomen Pathway at WWL
WWL enhances EPR for Acute Abdomen Pathway, improving patient outcomes and operational efficiency. 📈👩⚕️
May 15, 2026